Status: current, estado de definición: concepto suficientemente definido. Date: 31-Jul 2018. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | es un[a] | producto que contiene antazolina y xilometazolina en forma farmacéutica para administración ocular como únicos ingredientes (forma farmacéutica de producto medicinal) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | es un[a] | producto con antazolina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | es un[a] | preparados oculares misceláneos | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene como ingrediente activo | Antazoline (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | es un[a] | sulfato de antazolina+clorhidrato de xilometazolina (producto) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene como ingrediente activo | Antazoline sulfate (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene como ingrediente activo | clorhidrato de xilometazolina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene como ingrediente activo | Bronchodilator (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | es un[a] | producto con antazolina y xilometazolina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has manufactured dose form | forma farmacéutica para administración ocular (forma farmacéutica) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has manufactured dose form | Eye drops | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | es un[a] | producto que contiene xilometazolina en forma farmacéutica para administración oftálmica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator unit | ml | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | recuento de bases de ingrediente activo | 2 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator unit | ml | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene valor de numerador de potencia de concentración | 5 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene valor de numerador de potencia de concentración | 500 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene base de sustancia de la potencia | Antazoline sulfate (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has precise active ingredient | clorhidrato de xilometazolina | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has precise active ingredient | Antazoline sulfate (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | tiene base de sustancia de la potencia | clorhidrato de xilometazolina | true | relación inferida | restricción existencial (metadato del núcleo) | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets